Evidence map›Paper›PMID 27564111›Full record

ArticleOncotarget2016

Leptin induces osteocalcin expression in ATDC5 cells through activation of the MAPK-ERK1/2 signaling pathway.

Yingchao Han, Guanghui Xu, Jingjie Zhang, Meijun Yan, Xinhua Li, Bin Ma, Lili Jun, Shan-Jin Wang, Jun Tan

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yingchao HanDepartment of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, 200120, China.
Guanghui XuDepartment of Orthopedics, Shanghai Zhabei District Central hospital, Zhonghuaxin Road Zhabei District, Shanghai, 200070, China.
Jingjie ZhangDepartment of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, 200120, China.
Meijun YanDepartment of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, 200120, China.
Xinhua LiDepartment of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, 200120, China.
Bin MaDepartment of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, 200120, China.
Lili JunDepartment of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, 200120, China.
Shan-Jin WangDepartment of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, 200120, China.
Jun TanDepartment of Spine Surgery, Shanghai East Hospital, Tongji University, School of Medicine, Shanghai, 200120, China.
Shanghai East Hospital · CNShanghai Zhabei District Shibei Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both leptin and osteocalcin have been found to affect growth-plate cartilage development through regulation of the physiologic processes of endochondral bone formation. Leptin mediates bone development and osteocalcin secreted in the late stage of osteoblast differentiation. The relationship between leptin and osteocalcin expression in the chondrogenic cells line is still not clear. Thus, the aim of this study was to explore the effect of leptin on the expression of osteocalcin in chondrocytes. We used clonal mouse chondrogenic ATDC5 cells to investigate the relationship between leptin and osteocalcin. We found that both leptin and osteocalcin expression were dynamically expressed during ATDC5 cell differentiation from 4 to 21 days. We also found that leptin significantly upregulated osteocalcin mRNA and protein levels 24 h after leptin stimulation. However, different concentrations and exposure times of osteocalcin did not affect the levels of leptin protein. Furthermore, we confirmed that leptin augmented the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) in a time-dependent manner but not p38 or AKT. Inhibition of pERK1/2 expression by a specific ERK1/2 inhibitor U0126 and a special small interfering RNA attenuated levels of leptin-induced osteocalcin expression, indicating that ERK1/2 mediates, in part, the effects of leptin on osteocalcin. Taken together, our results suggest that leptin regulates the expression of osteocalcin in growth plate chondrocytes via the ERK1/2 signaling pathway, while there is no effect on the phosphorylation of either p38 or AKT.

Indexed as

MAP Kinase Signaling SystemAnimalsButadienesCell CountCell DifferentiationCell LineChondrocytesChondrogenesisExtracellular Signal-Regulated MAP KinasesLeptinMiceMitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesNitrilesOsteoblastsOsteocalcinButadienesExtracellular Signal-Regulated MAP KinasesLeptinMitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesNitrilesOsteocalcinRNA, Small InterferingU 0126ATDC5chondrocytegrowth plateleptinosteocalcin

Identifiers

PMID27564111
PMCPMC5325422
OpenAlexW2518192136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.